Anders Hedlund has been the CEO of Nolsterby Invest AB since 2021, a family office investing in the life science sector. Anders brings more than ten years of finance and investment banking experience in the life science sector. Between 2017 and 2021, Anders worked as an equity analyst at Redeye AB, covering companies predominantly within biotech and medtech. Before that, he had various finance positions in the GE Healthcare group. He has a master’s degree in business economics from Uppsala University and has also studied Human Physiology at the Karolinska Institute.
Independence: Dependent of the Company and the Executive Management and independent of major shareholders.
